go back

Dolasetron, Oral

Arkansas rates for HCPCS Q0180

Dolasetron mesylate, 100 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 24-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $59 · 10th–90th $59$620%50%90th$59Professionalmedian $60 · 10th–90th $58$720%50%10th90th$60$50.0$100.0$200.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$61.66
Median
$61.66
Typical High
$61.66
Aetna
Setting
Professional
Modifier
Global
Typical Low
$57.54
Median
$60.26
Typical High
$72.44
BCBS
Setting
Facility
Modifier
Global
Typical Low
$58.88
Median
$58.88
Typical High
$58.88
BCBS
Setting
Professional
Modifier
Global
Typical Low
$58.88
Median
$58.88
Typical High
$58.88
Cigna
Setting
Facility
Modifier
Global
Typical Low
$61.66
Median
$83.18
Typical High
$104.71
Cigna
Setting
Professional
Modifier
Global
Typical Low
$61.66
Median
$61.66
Typical High
$61.66
United
Setting
Professional
Modifier
Global
Typical Low
$57.54
Median
$60.26
Typical High
$69.18